Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
Cardiovascular device developer BioStable Science & Engineering said today it began a limited launch ofits HAART 300 aortic annuloplasty device, with the 1st commercial procedure being performed at the West Virginia University Heart and Vascular Institute.
The 1st procedure was performed by Dr. Lawrence Wei, Dr. Vinay Badhwar and Dr. J. Rankin, according to the Austin, Texas-based company. Read more
Defibrillator carrying drones could be diving in to save lives in the future, delivering equipment significantly faster than ambulances, according to a study published this week in the Journal of the American Medical Association.
Researchers in Sweden tested the theory that drones would be able to make it to emergency cardiac arrests faster than current system. In a simulated study, researchers found that the drones were able to arrive approximately 16 minutes faster than standard emergency systems on average, according to the JAMA article. Read more
The plaintiff in a $25 million lawsuit against a medical device company drew a 15-month sentence after admitting to lying on the stand during the trial, federal prosecutors said yesterday.
David Hernon pleaded guilty in late 2015 to “making false declarations before the court” when he and a business partner named Albert Davis sued Korean MRI scanner maker Isol Technology. Hernon and Davis, partners in a company called LBDS Holding Co., brought claims for breach of contract, trade secret misappropriation and unfair competition against Isol. Read more
Delpor Inc. said today that it won a $1.5 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to support the development of its exenatide implant.
The implant was designed for patients with Type II diabetes and features Delpor’s Nanopor technology, which uses passive diffusion to deliver therapeutic levels of exenatide for at least 3 months. Read more
Stryker today said it inked a deal with GE Additive, the 3D printing arm of GE Healthcare, for the equipment to build out its additive design and manufacturing facilities.
Stryker, which has already bought 3D printing machines from Arcam and Concept Laser, said the new deal involves machines, materials and services it will buy from GE Additive, which spent $1.4 billion to acquire a 75% stake in both Arcam and Concept Laser. Read more